Pzena Investment Management LLC Buys Shares of 603,206 Teleflex Incorporated $TFX

Pzena Investment Management LLC bought a new position in shares of Teleflex Incorporated (NYSE:TFX) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 603,206 shares of the medical technology company’s stock, valued at approximately $76,462,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. BlackRock Inc. acquired a new stake in shares of Teleflex in the 2nd quarter valued at approximately $688,537,000. Deutsche Bank AG acquired a new position in Teleflex during the 2nd quarter worth approximately $6,106,000. Rice Hall James & Associates LLC bought a new position in Teleflex in the 2nd quarter valued at approximately $578,000. Trust Co. of Vermont bought a new position in Teleflex in the 2nd quarter valued at approximately $57,000. Finally, Diamond Hill Capital Management LLC Investment Advisor acquired a new stake in Teleflex in the second quarter valued at approximately $39,467,000. Institutional investors own 95.62% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on TFX shares. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research note on Wednesday, June 24th. BMO Capital Markets initiated coverage on Teleflex in a research note on Wednesday, July 8th. They issued an “outperform” rating and a $159.00 price target for the company. Wells Fargo & Company raised their price objective on Teleflex from $130.00 to $138.00 and gave the company an “equal weight” rating in a report on Friday, May 8th. Needham & Company LLC boosted their price objective on Teleflex from $147.00 to $159.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Finally, Raymond James Financial restated an “outperform” rating and set a $150.00 price objective on shares of Teleflex in a research report on Friday, May 8th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Teleflex has a consensus rating of “Hold” and an average target price of $151.80.

Teleflex Stock Down 3.0%

NYSE:TFX opened at $133.05 on Tuesday. Teleflex Incorporated has a one year low of $100.18 and a one year high of $145.00. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.60 and a quick ratio of 2.12. The company has a market cap of $5.64 billion, a PE ratio of -5.71, a P/E/G ratio of 0.91 and a beta of 0.81. The firm’s 50 day simple moving average is $132.40 and its 200 day simple moving average is $124.01.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.48. The firm had revenue of $570.33 million during the quarter, compared to analysts’ expectations of $559.59 million. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The company’s revenue was up 28.9% on a year-over-year basis. During the same period in the prior year, the company posted $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. On average, research analysts anticipate that Teleflex Incorporated will post 7.26 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Friday, August 14th will be paid a $0.34 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex’s payout ratio is currently -5.84%.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.